(Q44745249)

5 December 2017

Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism (English)

1 reference

5 December 2017

1 reference

2

Adriana Zeevi

1 reference

5 December 2017

HongXia Zheng

1

1 reference

5 December 2017

Erin Schuetz

3

1 reference

5 December 2017

Jatinder Lamba

4

1 reference

5 December 2017

Kenneth McCurry

5

1 reference

5 December 2017

Bartley P Griffith

6

1 reference

5 December 2017

Steven Webber

7

1 reference

5 December 2017

Julianne Ristich

8

1 reference

5 December 2017

James Dauber

9

1 reference

5 December 2017

Aldo Iacono

10

1 reference

5 December 2017

Wayne Grgurich

11

1 reference

5 December 2017

Diana Zaldonis

12

1 reference

5 December 2017

Kevin McDade

13

1 reference

5 December 2017

Jiong Zhang

14

1 reference

5 December 2017

Gilbert J Burckart

15

1 reference

5 December 2017

1 February 2004

1 reference

The Journal of Clinical Pharmacology

5 December 2017

1 reference

5 December 2017

44

1 reference

5 December 2017

2

1 reference

5 December 2017

135-140

1 reference

Tacrolimus is a class II low-solubility high-permeability drug: the effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats

5 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

Automating the identification of DNA variations using quality-based fluorescence re-sequencing: analysis of the human mitochondrial genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

Clinical pharmacokinetics of tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

Racial variation in dosage requirements of tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient: possible relationship to intestinal P-glycoprotein activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003262108

21 January 2018

Identifiers

DOI

10.1177/0091270003262108

1 reference

5 December 2017

1 reference